Rebates Would Be Eliminated In Commercial Market Under Senate Bill
Legislation by Sen. Mike Braun, R-Ind., would apply to the private insurance market changes proposed by the HHS Office of Inspector General for Medicare and Medicaid managed care plans.
You may also be interested in...
Part D Premiums ‘Won’t Go Up’ With HHS Rebate Proposal, Azar Maintains
US HHS secretary tells Senate Finance Committee he believes pharmacy benefit managers will effectively keep drug costs down in Medicare Part D, even without rebates.
Big Pharma At The Senate: When It Comes To Yes Or No Questions, There Are Still A Few Maybes
Our question-by-question infographic shows how Rx executives exhibited enough finesse to avoid any embarrassing sound bites at the Senate Finance Committee hearing on drug pricing.